IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,721,807 | -10.2% | 801,849 | -0.8% | 0.01% | 0.0% |
| Q2 2023 | $8,603,045 | -3.7% | 808,557 | -4.8% | 0.01% | 0.0% |
| Q1 2023 | $8,932,711 | -17.5% | 849,117 | -2.8% | 0.01% | -25.0% |
| Q4 2022 | $10,821,946 | +13.0% | 873,442 | -5.5% | 0.01% | 0.0% |
| Q3 2022 | $9,577,000 | -32.4% | 924,443 | -24.7% | 0.01% | -20.0% |
| Q2 2022 | $14,157,000 | +340.3% | 1,227,803 | +380.4% | 0.01% | +400.0% |
| Q1 2022 | $3,215,000 | -23.3% | 255,572 | -28.9% | 0.00% | -33.3% |
| Q4 2021 | $4,194,000 | -8.4% | 359,669 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $4,579,000 | +6.3% | 350,610 | +4.7% | 0.00% | 0.0% |
| Q2 2021 | $4,309,000 | +37.3% | 334,781 | +19.3% | 0.00% | +50.0% |
| Q1 2021 | $3,138,000 | +2.8% | 280,680 | +4.7% | 0.00% | 0.0% |
| Q4 2020 | $3,054,000 | +6.2% | 268,181 | -16.2% | 0.00% | 0.0% |
| Q3 2020 | $2,877,000 | +39.1% | 319,840 | +59.6% | 0.00% | 0.0% |
| Q2 2020 | $2,069,000 | +372.4% | 200,443 | +361.3% | 0.00% | – |
| Q1 2020 | $438,000 | -23.6% | 43,456 | +1.0% | 0.00% | – |
| Q4 2019 | $573,000 | +27.9% | 43,043 | -17.5% | 0.00% | – |
| Q3 2019 | $448,000 | -14.0% | 52,177 | +9.6% | 0.00% | – |
| Q2 2019 | $521,000 | -4.1% | 47,617 | +18.6% | 0.00% | -100.0% |
| Q1 2019 | $543,000 | +36.4% | 40,134 | +4.4% | 0.00% | – |
| Q4 2018 | $398,000 | -54.7% | 38,448 | -19.2% | 0.00% | -100.0% |
| Q3 2018 | $879,000 | +12.8% | 47,601 | +16.7% | 0.00% | 0.0% |
| Q2 2018 | $779,000 | +17.9% | 40,772 | -4.8% | 0.00% | 0.0% |
| Q1 2018 | $661,000 | +2.5% | 42,833 | -0.5% | 0.00% | 0.0% |
| Q4 2017 | $645,000 | -53.7% | 43,054 | -51.2% | 0.00% | 0.0% |
| Q3 2017 | $1,392,000 | -18.5% | 88,261 | -2.5% | 0.00% | -50.0% |
| Q2 2017 | $1,709,000 | +316.8% | 90,522 | +276.4% | 0.00% | – |
| Q1 2017 | $410,000 | +11.7% | 24,051 | +0.3% | 0.00% | – |
| Q4 2016 | $367,000 | +0.3% | 23,989 | +4.2% | 0.00% | – |
| Q3 2016 | $366,000 | +22.8% | 23,025 | +1.1% | 0.00% | – |
| Q2 2016 | $298,000 | +22.6% | 22,769 | +2.6% | 0.00% | – |
| Q1 2016 | $243,000 | -3.6% | 22,199 | +2.1% | 0.00% | – |
| Q4 2015 | $252,000 | +13.5% | 21,747 | +2.1% | 0.00% | – |
| Q3 2015 | $222,000 | -15.3% | 21,307 | -1.9% | 0.00% | – |
| Q2 2015 | $262,000 | -26.0% | 21,712 | -1.9% | 0.00% | -100.0% |
| Q1 2015 | $354,000 | +19.6% | 22,143 | +14.7% | 0.00% | – |
| Q4 2014 | $296,000 | -8.1% | 19,297 | -22.4% | 0.00% | -100.0% |
| Q3 2014 | $322,000 | -15.5% | 24,872 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $381,000 | +20.6% | 24,872 | -2.9% | 0.00% | 0.0% |
| Q1 2014 | $316,000 | +5.3% | 25,612 | -0.9% | 0.00% | 0.0% |
| Q4 2013 | $300,000 | -2.0% | 25,855 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $306,000 | -0.6% | 25,855 | -16.3% | 0.00% | 0.0% |
| Q2 2013 | $308,000 | – | 30,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |